[Antineoplastic effect of the antibiotics rubomycin B and C in experimental conditions].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003864:Depression, Chemical; D007275:Injections, Intravenous; D007942:Leukemia, Experimental / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009929:Organ Size; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy; D013154:Spleen / Q000033:anatomy & histology
D000903:Antibiotics, Antineoplastic
Protivoopukholevia aktivnost' antibiotikov rubomitsinov B i C v eksperimente.